Headlines and hot topics from ASCO and BIO, with Jonah Comstock

This week, pharmaphorum editor-in-chief Jonah Comstock headed to not one, but two back-to-back events in the US.

Starting with the American Society of Clinical Oncology’s (ASCO) annual conference in Chicago, before hitting the floor at the BIO International Convention in Boston, there was plenty of innovation, news, and expert knowledge on display.

Fresh from the floor of BIO International, Jonah sat down with pharmaphorum Deep Dive editor Eloise McLennan to reflect on the biggest topics and trends from each event – and the impact these developments may have on pharma over the coming months.

Topics discussed include the controversial Inflation Reduction Act and its implications for pharma, balancing access and evidence in accelerated approvals, and why drugmakers are searching for multiple indications for therapeutics.

You can listen to episode 88 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series - on iTunes, Spotify, Stitcher, and Podbean.